CIK 0001842295
- Non-accelerated filer
- Emerging growth company
Maze Therapeutics, Inc.
Sign in to watch- Ticker
- MAZE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-850-5070
- Business address
- 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,785,701
- in 13 filings, $4.6M under 10b5-1 plans
Net −$5,785,701. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −2,257 | $30.12 | $68K | 13,301 |
| 2026-11-02 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −336 | $30.91 | $10K | 12,965 |
| 2026-11-02 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −26,563 | $30.10 | $799K | 164,884 |
| 2026-11-02 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −5,345 | $31.05 | $166K | 186,901 |
| 2026-10-01 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −2,593 | $27.02 | $70K | 15,558 |
| 2026-10-01 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −31,908 | $27.02 | $862K | 191,447 |
| 2026-09-03 | Coloma Jason V Chief Executive Officer | Sale | −11,282 | $26.01 | $293K | 27,491 |
| 2026-09-03 | Coloma Jason V Chief Executive Officer | Sale | −129 | $25.77 | $3K | 27,362 |
| 2026-09-02 | Coloma Jason V Chief Executive Officer | Sale | −9,852 | $26.38 | $260K | 40,148 |
| 2026-09-02 | Coloma Jason V Chief Executive Officer | Sale | −1,375 | $27.12 | $37K | 38,773 |
| 2026-09-01 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −2,593 | $26.31 | $68K | 18,151 |
| 2026-09-01 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −31,908 | $26.29 | $839K | 223,355 |
| 2026-09-01 | Coloma Jason V Chief Executive Officer | Option exercise 10b5-1 | +50,000 | 50,000 | ||
| 2026-09-01 | Coloma Jason V Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −50,000 | 50,000 | ||
| 2026-08-03 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −2,439 | $26.71 | $65K | 20,898 |
| 2026-08-03 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −154 | $27.09 | $4K | 20,744 |
| 2026-08-03 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −30,304 | $26.71 | $810K | 256,867 |
| 2026-08-03 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −1,604 | $27.09 | $43K | 255,263 |
| 2026-07-01 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −2,593 | $29.98 | $78K | 23,337 |
| 2026-07-01 | Coloma Jason V Chief Executive Officer | Sale 10b5-1 | −30,311 | $29.95 | $908K | 288,768 |
Page 1 of 2 · 34 trades